Regen BioPharma Inc SEC filings RGBP
Regen BioPharma Inc has 263 filings in SEC EDGAR's recent list, going back to Oct 15, 2013. Its latest annual report, Form 10-K, was filed on Dec 30, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | May 29, 2024 | — |
| 424B3 | Prospectus | May 23, 2024 | — |
| 424B3 | Prospectus | May 10, 2024 | — |
| 424B3 | Prospectus | Apr 29, 2024 | — |
| 424B3 | Prospectus | Apr 24, 2024 | — |
| 424B3 | Prospectus | Feb 9, 2024 | — |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| 424B3 | Prospectus | Nov 20, 2023 | — |
| 424B3 | Prospectus | Oct 2, 2023 | — |
| S-1 | Registration statement | Sep 25, 2023 | — |
| 424B3 | Prospectus | May 15, 2023 | — |
| S-1/A | Amended registration statement | May 2, 2023 | — |
| S-1 | Registration statement | Apr 13, 2023 | — |
| S-8 | Employee stock plan registration | Jun 30, 2015 | — |
| 424B3 | Prospectus | Mar 19, 2014 | — |
| S-1/A | Amended registration statement | Feb 28, 2014 | — |
| S-1/A | Amended registration statement | Feb 25, 2014 | — |
| S-1/A | Amended registration statement | Jan 14, 2014 | — |
| S-1/A | Amended registration statement | Nov 22, 2013 | — |
| S-1 | Registration statement | Oct 15, 2013 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RGBP (OTC), RGBPP (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- La Mesa, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1589150
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.